Women’s Tennis Association unveils rule protecting players’ rankings during fertility procedures

Women’s Tennis Association unveils rule protecting players’ rankings during fertility procedures


Sloane Stephens looks on against Madison Keys during the Charlotte Invitational at Spectrum Center on December 06, 2024 in Charlotte, North Carolina.

Jacob Kupferman | Getty Images

The Women’s Tennis Association has introduced a rule allowing players to protect their rankings during fertility treatments.

The policy means that players can step away from professional tennis to undergo procedures like egg or embryo freezing and return to the tour with a protected ranking.

Players must be out for 10 consecutive weeks for a procedure, and they receive a “Special Entry Ranking” based on their recent averages. It can be used for three tournaments after coming back.

“The WTA has now created a safe space for players to explore options and to make the best decisions for themselves,” eight-time WTA champion Sloane Stephens said in a press release.

The rule expands the WTA’s existing support programs, such as maternity leave, postpartum support and fertility grants.

“We are committed to supporting WTA players as they navigate and balance the choices associated with career and family,” said WTA CEO Portia Archer in a press release.

The move comes as female athletes have been pushing to grow efforts to address fertility challenges.



Source

Kimberly-Clark agrees to buy Tylenol owner Kenvue in .7 billion deal, creating consumer staples giant
Business

Kimberly-Clark agrees to buy Tylenol owner Kenvue in $48.7 billion deal, creating consumer staples giant

Huggies, manufactured by Kimberly-Clark and Band-Aid, manufactured by Kenvue. Getty Images Kimberly-Clark announced Monday it’s struck an agreement to buy Kenvue in a deal valued at $48.7 billion that would create a consumer staples giant. The deal is a combination of cash and stock. Shares of Kenvue surged 20% in premarket trading Monday, while shares […]

Read More
Where the blockbuster weight loss drug market stands today — and what’s coming next
Business

Where the blockbuster weight loss drug market stands today — and what’s coming next

A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Hollie Adams | Reuters The appetite for blockbuster weight loss and diabetes drugs is far from satisfied.  From fresh competition to new uses, the market is quickly vaulting into a new stage of […]

Read More
Just 5% of CRE companies have achieved their AI goals. Here’s why
Business

Just 5% of CRE companies have achieved their AI goals. Here’s why

Diminishing perspective of downtown London skyscrapers Chunyip Wong | Istock | Getty Images A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large […]

Read More